Skip to main content
. 2017 May 8;8(32):52983–52994. doi: 10.18632/oncotarget.17677

Figure 9. Expression levels of miR-133b and ABCC1 in xenograft.

Figure 9

(A) The expression of miR-133b increased in xenograft treated with agomiRNA-133b. (B) Contrarily, the expression level of ABCC1 decreased in the agomiRNA-133b group, as detected by Western blot. (C) Immunohistochemical staining of ABCC1 in xenograft also showed the decreased level in agomiRNA-133b group. The data are expressed as the mean ± standard deviation. The results are representative of three independent experiments. *P<0.05.